Ticovac Market Report 2026

Ticovac Market Overview

• The Ticovac market growth in the historic period has been driven by endemic presence of tick-borne encephalitis, public health vaccination initiatives • Market expansion is supported by expansion of vaccination coverage in europe, rising travel to endemic regions • Growth Driver: Rising Prevalence Of Tick-Borne Diseases Driving Growth In The Ticovac Market • Market Trend: Suspension Formulation Boosts Competitive Edge In The Ticovac Market • Europe was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Ticovac Market?

TicoVac is a vaccine used to protect against tick-borne encephalitis (TBE), a viral disease transmitted primarily through tick bites or, less commonly, by consuming unpasteurized dairy products from infected animals. TBE affects the central nervous system and can lead to severe neurological complications, including meningitis and encephalitis. TicoVac works by stimulating the immune system to recognize and fight the tick-borne encephalitis virus (TBEV) if exposed in the future. The main types of ticovac formulations are inactivated vaccines and live attenuated vaccines. Tick-borne encephalitis is a viral infection transmitted through the bite of infected ticks, affecting the central nervous system and potentially leading to severe neurological complications. It is used for tick-borne encephalitis, Japanese encephalitis, and rabies encephalitis and is distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Ticovac Market Growth Forecast?

The ticovac market size is expected to see strong growth in the next few years. It will grow to $6.11 million in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to expansion of vaccination coverage in europe, rising travel to endemic regions, increasing climate driven tick populations, stronger preventive healthcare policies, investment in vaccine infrastructure. Major trends in the forecast period include rising demand for tick-borne disease vaccination, expansion of preventive travel immunization, growth of government led vaccination programs, increased awareness of vector-borne diseases, improved cold chain vaccine distribution.

What Are The Drivers Of The Ticovac Market?

The rising prevalence of tick-borne diseases is expected to drive the growth of the ticovac market going forward. Tick-borne diseases are illnesses transmitted to humans through the bite of infected ticks, caused by bacteria, viruses, or parasites. Tick-borne diseases are rising due to climate change, expanding tick habitats, increased human exposure, and better diagnostics. Ticovac is required for tick-borne diseases as it provides active immunization against tick-borne encephalitis (TBE), a potentially severe viral infection transmitted through tick bites. For instance, in February 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the overall incidence of Lyme disease was 18.9 cases per 100,000 population, with a rate 68.8% higher than in previous years. Among high-incidence jurisdictions, the median rate was 58% higher at 68.3 cases per 100,000, while for children aged 5–9 years, the incidence was 16.5 cases per 100,000, reflecting an 11.5% increase. Therefore, the rising prevalence of tick-borne diseases is driving the growth of the ticovac industry. The increasing research and development activities are expected to drive the growth of the ticovac market going forward. Research and development (R&D) activities involve the systematic investigation and innovation aimed at creating new products, improving existing ones, or developing new technologies and solutions through scientific and technical research. Research and development activities are rising due to the growing demand for innovation, technological advancements, and the need to address emerging global challenges in various industries. Research and development activities positively impact TicoVac by driving advancements in vaccine formulation, enhancing efficacy, and ensuring its continued ability to address emerging strains of tick-borne encephalitis. For instance, in February 2025, according to the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, U.S. research and development expenditures rose from $892 billion in 2022 to $940 billion in 2023, reflecting an increase of $48 billion. Therefore, the increasing research and development activities are driving the growth of the ticovac industry.

Key Players In The Global Ticovac Market

Major companies operating in the ticovac market are Pfizer Inc.

Global Ticovac Market Trends and Insights

Major companies operating in the ticovac market are focusing on innovative formulations such as suspension liquid to gain a competitive edge in the industry. Suspension liquid is a vaccine formulation for the prevention of tick-borne encephalitis, available for intramuscular injection. It comes in a 0.5 mL dose and is designed for both adult and pediatric use. For instance, in September 2024, Pfizer Inc., a US-based pharmaceutical manufacturer, launched Ticovac, a vaccine aimed at preventing tick-borne encephalitis (TBE), a viral infection that affects the brain and spinal cord. The vaccine is the first of its kind in Japan, offering protection against the disease in regions where it is prevalent. The vaccine is available in two versions, one for adults and one for children, both as a 0.5 mL intramuscular injection.

What Defines the Ticovac Market?

The ticovac market consists of sales of pediatric vaccines, cardiovascular and metabolic products, anti-infective medications and rare disease medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ticovac Market Report 2026?

The ticovac market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ticovac industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.